Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    CTI BioPharma Corp.

    NASDAQ: CTIC · Real-Time Price · USD
    9.10
    0.01 (0.11%)
    At close: Jun 23, 2023, 9:58 PM

    CTI BioPharma Statistics

    Share Statistics

    CTI BioPharma has 131.88M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 131.88M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 99.89M

    Failed to Deliver (FTD) Shares

    n/a
    		 990,029

    FTD / Avg. Volume

    n/a
    		 17.49%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -7.57 and the forward PE ratio is null. CTI BioPharma's PEG ratio is 0.26.

    PE Ratio

    n/a
    		 -7.57

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 12.78

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 -39.22

    P/FCF Ratio

    n/a
    		 -6.49

    PEG Ratio

    n/a
    		 0.26
    Financial Ratio History

    Enterprise Valuation

    CTI BioPharma has an Enterprise Value (EV) of 708.85M.

    EV / Sales

    n/a
    		 13.14

    EV / EBITDA

    n/a
    		 -8.88

    EV / EBIT

    n/a
    		 -8.73

    EV / FCF

    n/a
    		 -6.68

    Financial Position

    The company has a current ratio of 1.23, with a Debt / Equity ratio of -2.73.

    Current Ratio

    n/a
    		 1.23

    Quick Ratio

    n/a
    		 1.22

    Debt / Equity

    n/a
    		 -2.73

    Debt / EBITDA

    n/a
    		 -0.63

    Debt / FCF

    n/a
    		 -0.47

    Interest Coverage

    n/a
    		 -6.07

    Financial Efficiency

    Return on Equity is 517.96% and Return on Invested Capital is -257.27%.

    Return on Equity

    n/a
    		 517.96%

    Return on Assets

    n/a
    		 -72.3%

    Return on Invested Capital

    n/a
    		 -257.27%

    Revenue Per Employee

    n/a
    		 $424,787.4

    Profits Per Employee

    n/a
    		 $-716,858.27

    Employee Count

    n/a
    		 127

    Asset Turnover

    n/a
    		 0.43

    Inventory Turnover

    n/a
    		 4.79

    Taxes

    Income Tax

    n/a
    		 -1.95M

    Effective Tax Rate

    n/a
    		 2.1%

    Stock Price Statistics

    The stock price has increased by 0.11% in the last 52 weeks. The beta is 0.83, so CTI BioPharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.83

    52-Week Price Change

    n/a
    		 0.11%

    50-Day Moving Average

    n/a
    		 7.44

    200-Day Moving Average

    n/a
    		 5.87

    Relative Strength Index (RSI)

    n/a
    		 83.62

    Average Volume (20 Days)

    n/a
    		 5,661,603

    Income Statement

    In the last 12 months, CTI BioPharma had revenue of 53.95M and earned -91.04M in profits. Earnings per share was -0.79.

    Revenue

    n/a
    		 53.95M

    Gross Profit

    n/a
    		 50.43M

    Operating Income

    n/a
    		 -79.8M

    Net Income

    n/a
    		 -91.04M

    EBITDA

    n/a
    		 -79.85M

    EBIT

    n/a
    		 -79.85M

    Earnings Per Share (EPS)

    n/a
    		 -0.79
    Full Income Statement

    Balance Sheet

    The company has 30.42M in cash and 49.96M in debt, giving a net cash position of -19.54M.

    Cash & Cash Equivalents

    n/a
    		 30.42M

    Total Debt

    n/a
    		 49.96M

    Net Cash

    n/a
    		 -19.54M

    Retained Earnings

    n/a
    		 -2.52B

    Total Assets

    n/a
    		 112.27M

    Working Capital

    n/a
    		 18.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -81.19M and capital expenditures -25M, giving a free cash flow of -106.19M.

    Operating Cash Flow

    n/a
    		 -81.19M

    Capital Expenditures

    n/a
    		 -25M

    Free Cash Flow

    n/a
    		 -106.19M

    FCF Per Share

    n/a
    		 -0.93
    Full Cash Flow Statement

    Margins

    Gross margin is 93.49%, with operating and profit margins of -147.91% and -168.76%.

    Gross Margin

    n/a
    		 93.49%

    Operating Margin

    n/a
    		 -147.91%

    Pretax Margin

    n/a
    		 -172.37%

    Profit Margin

    n/a
    		 -168.76%

    EBITDA Margin

    n/a
    		 -148.02%

    EBIT Margin

    n/a
    		 -147.91%

    FCF Margin

    n/a
    		 -196.85%

    Dividends & Yields

    CTIC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -13.21%

    FCF Yield

    n/a
    		 -15.41%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for CTIC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 1.65

    Graham Upside

    n/a
    		 -81.87%

    Stock Splits

    The last stock split was on Jan 3, 2017. It was a backward split with a ratio of 1:10.

    Last Split Date

    n/a
    		 Jan 3, 2017

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:10

    Scores

    Altman Z-Score

    n/a
    		 -27.06

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist